Skip to main content

Table 3 Application of the described method for determination of ritonavir in the pharmaceutical preparation with statistical assessment of the obtained results with the others obtained by the reported one

From: Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma

Parameter

Described Method

Reported method [11]

Mean a

100.13

100.32

SD a

1.063

1.398

Variance a

1.1235

1.958

t-test

0.248 (2.306)b

------

F-value

1.718 (6.388)b

  1. a Mean recovery, % of five concentration sets
  2. b The values in the parenthesis are the corresponding theoretical values of t and F at (P = 0.05)
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us